• LAST PRICE
    1.3400
  • TODAY'S CHANGE (%)
    Trending Up0.0800 (6.3492%)
  • Bid / Lots
    1.3300/ 58
  • Ask / Lots
    1.3400/ 6
  • Open / Previous Close
    1.2600 / 1.2600
  • Day Range
    Low 1.2600
    High 1.3850
  • 52 Week Range
    Low 0.4126
    High 1.9280
  • Volume
    751,101
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 1.26
TimeVolumeNKTR
09:32 ET248131.315
09:34 ET92791.295
09:36 ET31301.295
09:38 ET144681.2905
09:39 ET48501.28
09:41 ET28451.29
09:43 ET23001.28
09:45 ET4001.28
09:48 ET122061.29
09:50 ET4981.28
09:52 ET40071.275
09:54 ET11281.272
09:56 ET60001.2798
09:57 ET6981.28
09:59 ET21581.27
10:01 ET78531.275
10:03 ET4481.27
10:06 ET11051.27
10:08 ET29181.265
10:10 ET106951.27
10:12 ET151571.275
10:14 ET2001.27
10:15 ET87161.295
10:17 ET46581.295
10:19 ET264711.315
10:21 ET35871.315
10:24 ET135641.325
10:26 ET74991.34
10:28 ET132811.34
10:30 ET354101.355
10:32 ET234091.3595
10:33 ET42461.3675
10:35 ET21221.3654
10:37 ET39971.37
10:39 ET229311.36
10:42 ET7871.355
10:44 ET11431.35
10:46 ET173021.35
10:48 ET89671.345
10:50 ET3501.35
10:51 ET187641.37
10:53 ET14001.37
10:55 ET335191.3695
10:57 ET31721.36
11:00 ET49071.3501
11:04 ET19871.355
11:06 ET35341.355
11:08 ET7001.355
11:09 ET4441.3575
11:11 ET26001.3575
11:13 ET5001.3575
11:15 ET6001.3575
11:18 ET12001.3575
11:20 ET15001.3575
11:22 ET23001.355
11:24 ET20001.355
11:26 ET2001.355
11:27 ET13001.355
11:29 ET2541.36
11:31 ET4001.355
11:33 ET15161.355
11:36 ET119971.34
11:38 ET75711.33
11:40 ET1001.33
11:42 ET3301.335
11:44 ET2001.33
11:45 ET14201.335
11:47 ET145101.325
11:49 ET10001.3201
11:51 ET4001.325
11:54 ET1001.325
11:56 ET144071.32
11:58 ET4901.325
12:00 ET11221.325
12:02 ET8001.33
12:03 ET23001.325
12:05 ET10771.325
12:07 ET39001.325
12:09 ET21171.325
12:12 ET7911.32
12:14 ET8471.325
12:16 ET10001.32
12:18 ET123331.32
12:20 ET2001.315
12:21 ET18931.315
12:23 ET53001.315
12:25 ET67001.32
12:27 ET17001.32
12:30 ET64761.33
12:32 ET4001.325
12:34 ET13361.325
12:36 ET10141.325
12:38 ET12001.325
12:39 ET5001.33
12:41 ET9001.33
12:43 ET80641.33
12:45 ET10531.33
12:48 ET6001.33
12:50 ET46001.325
12:52 ET15001.33
12:54 ET92931.31
12:56 ET198581.3199
12:57 ET8001.315
12:59 ET103881.325
01:01 ET13001.325
01:03 ET40001.325
01:06 ET14001.33
01:08 ET113391.325
01:10 ET3041.325
01:12 ET4001.33
01:14 ET85721.34
01:15 ET3001.34
01:17 ET33001.335
01:19 ET46001.34
01:21 ET3001.34
01:24 ET18001.335
01:26 ET123841.325
01:28 ET12721.33
01:30 ET2001.33
01:32 ET5001.325
01:33 ET4001.325
01:35 ET23001.325
01:37 ET5001.325
01:39 ET2611.325
01:42 ET132751.32
01:44 ET12001.32
01:46 ET14061.325
01:48 ET11521.325
01:50 ET1001.325
01:51 ET26001.325
01:53 ET6671.325
01:55 ET103921.33
01:57 ET129601.33
02:00 ET25001.33
02:02 ET41651.325
02:04 ET7981.325
02:06 ET5001.33
02:08 ET11671.33
02:09 ET8001.33
02:11 ET155921.34
02:13 ET7001.34
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNKTR
Nektar Therapeutics
221.3M
-1.5x
---
United StatesLFCR
Lifecore Biomedical Inc
180.2M
-2.6x
---
United StatesOPTN
OptiNose Inc
169.5M
-4.7x
---
United StatesRMTI
Rockwell Medical Inc
57.1M
-5.2x
---
United StatesSMTI
Sanara Medtech Inc
282.0M
-55.2x
---
United StatesDERM
Journey Medical Corp
78.6M
-19.4x
---
As of 2024-06-12

Company Information

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company. The Company is focused on discovering and developing medicines in the field of immunotherapy. The Company has a research and development pipeline of investigational medicines in immunology and oncology. In oncology, it is focused on developing medicines based on targeting biological pathways that stimulate and sustain the body’s immune response to fight cancer. Its pipeline includes NKTR-255, Rezpegaldesleukin (REZPEG) and NKTR-0165. NKTR-255 is an investigational biologic that is designed to target the interleukin-15 (IL-15) pathway in order to activate the body’s innate and adaptive immunity. Its Rezpegaldesleukin pipeline is an investigational, potential first-in-class T regulatory cell stimulator that addresses this underlying immune system imbalance in people with many autoimmune and inflammatory conditions. Rezpegaldesleukin is being developed as a self-administered injection.

Contact Information

Headquarters
455 Mission Bay Boulevard SouthSAN FRANCISCO, CA, United States 94158
Phone
415-482-5300
Fax
415-339-5300

Executives

Independent Chairman of the Board
Robert Chess
President, Chief Executive Officer
Howard Robin
Interim Chief Financial Officer
Sandra Gardiner
Senior Vice President, Chief Legal Officer
Mark Wilson
Chief Research and Development Officer
Jonathan Zalevsky

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$221.3M
Revenue (TTM)
$90.2M
Shares Outstanding
183.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.67
EPS
$-0.92
Book Value
$0.68
P/E Ratio
-1.5x
Price/Sales (TTM)
2.5
Price/Cash Flow (TTM)
---
Operating Margin
-182.33%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.